Via Business of Cannabis Portugal’s cannabis regulator has approved three new cannabis preparations for its medical cannabis programme, marking the...
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
More details of how France’s long-awaited medical cannabis generalisation will look have been published.
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
Cash has described CBD as a ‘gamechanger’ for athletes living with chronic pain.
Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals, explores the latest developments in Ukraine.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
Almost six years since the law change, children still struggle to access a consistent supply of medicine in the UK, writes Matt Hughes, Medcan Family Foundation.